The latest Investing Matters Podcast with Jean Roche, Co-Manager of Schroder UK Mid Cap Investment Trust has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPci-pal Regulatory News (PCIP)

Share Price Information for Pci-pal (PCIP)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 66.50
Bid: 64.00
Ask: 69.00
Change: 0.00 (0.00%)
Spread: 5.00 (7.813%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 66.00
PCIP Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Patent Case Update

10 Nov 2021 07:00

RNS Number : 8561R
PCI-PAL PLC
10 November 2021
 

 

PCI-PAL PLC

("PCI Pal", "the Company" or "the Group")

Patent Case Update

 

PCI-PAL PLC (AIM: PCIP), the global cloud provider of secure payment solutions for business communications, provides an update on the on-going lawsuit filed by its competitor in the UK and US in September 2021.

 

As notified on 16 September 2021, one of PCI Pal's competitors, the US private equity owned, UK company, Semafone Limited, commenced litigation proceedings against the Company in the UK and the US for alleged patent infringement, which relates to one aspect of how one of the Company's products functions. As previously stated, PCI Pal strongly refutes these claims.

 

PCI Pal has this week filed its UK defence and counterclaim to the UK Court in response to the claims, and has summarised two headline points from this filing below:

 

1. PCI Pal does not infringe the patents as claimed by Semafone;

2. The patent is invalid. It lacks novelty and inventive step over the prior art1;

 

PCI Pal believes that the filing shows a strong defence and, in addition to non-infringement, has provided the Court with information on prior art and invalidity arguments. The Court will assess these points and Semafone's arguments and opine accordingly.

 

In the US, PCI Pal has also started the defence of the claims being made.

 

In the last week, PCI Pal has made an application to the US Court for it to invalidate the Semafone US patents under section 101 of the US Patent Act. The Company believes those patents are overly abstract and thus do not qualify for patentable subject matter under the US patent laws. PCI Pal has made this application to ensure it does not spend significant time and resources on further defence points, based around non-infringement and prior art based invalidity, before having the eligibility of the patents reviewed by the US Court. PCI Pal expects to understand the Court's position on this motion in the next few months.

 

PCI Pal is well funded, with no debt, and given the continued strong trading announced today is in a good position to deal with these allegations. The Group will be reporting costs associated with its defence of these allegations as exceptional items in its accounts.

 

PCI Pal is working with its well-established team of advisors to work towards an outcome that it believes will best benefit the Company, whilst at the same time focusing on delivering its strategic growth plans based on the established momentum within the Group.

 

Given the nature of the claims being made against PCI Pal, it is limited in the information it can provide on the case, but the Board will endeavour to keep investors updated as appropriate.

 

 

1Section 2(1) of the Patents Act 1977 Act states that an invention shall be taken to be new if it does not form part of the state of the art. Section 2(2) then goes on to define the state of the art as to be taken to comprise all matter (whether a product, a process, information about either, or anything else) which has at any time before the priority date of the invention been made available to the public (whether in the UK or elsewhere) by written or oral description, by use or in any other way. This is generally known as "prior art".

 

For further information, please contact:

 

PCI-PAL PLC

Via Walbrook PR

James Barham - Chief Executive Officer

William Good - Chief Financial Officer

 

 

finnCap (Nominated Adviser and Broker)

+44 (0) 20 7227 0500

Marc Milmo/Simon Hicks (Corporate Finance)

Richard Chambers (Corporate Broking)

 

 

Walbrook PR

+44 (0) 20 7933 8780

Tom Cooper/Nick Rome

+44 (0) 797 122 1972

 

PCIPAL@walbrookpr.com

 

About PCI Pal:

 

PCI Pal is a leading provider of Software-as-a-Service ("SaaS") solutions that empower companies to take payments from their customers securely, adhere to strict industry governance, and remove their business from the significant risks posed by non-compliance and data loss. Our products secure payments and data in any business communications environment including voice, chat, social, email, and contact centre. We are integrated to, and resold by, some of the worlds' leading business communications vendors, as well as major payment service providers.

 

The entirety of our product-base is available from our global cloud platform hosted in Amazon Web Services ("AWS"), with regional instances across EMEA, North America, and ANZ.

 

For more information visit www.pcipal.com or follow the team on Linkedin: https://www.linkedin.com/company/pci-pal/

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
MSCEAXFNEFDFFFA
Date   Source Headline
3rd May 20177:00 amRNSHolding(s) in Company
3rd May 20177:00 amRNSHolding(s) in Company
27th Apr 20177:00 amRNSDirector/PDMR Shareholding
26th Apr 20177:00 amRNSSignificant contract with international business
7th Apr 20177:00 amRNSNew contract awards
24th Mar 20177:00 amRNSDirectorate Change
22nd Feb 20177:00 amRNSHalf-year Report
21st Feb 20173:52 pmRNSHolding(s) in Company
19th Jan 201711:30 amRNSTrading Update, Notice of Results & Board Change
16th Dec 201611:33 amRNSResult of AGM
16th Dec 20167:00 amRNSDirectors' Dealings
5th Dec 20165:25 pmRNSHolding(s) in Company
25th Nov 20164:05 pmRNSHolding(s) in Company
23rd Nov 20164:27 pmRNSDirector Dealing
23rd Nov 20167:00 amRNSFinal Results
7th Nov 201612:30 pmRNSSpecial Dividend and Dividend Timetable
4th Oct 20167:00 amRNSChange of TIDM to PCIP
3rd Oct 20167:00 amRNSUpdate on Company Changes & Change of Name
30th Sep 20161:00 pmRNSCompletion of Disposal & Company Changes Update
30th Sep 201611:00 amRNSResult of General Meeting & Change of Name
14th Sep 20164:17 pmRNSHolding(s) in Company
12th Sep 20167:00 amRNSDisposal - Replacement
9th Sep 20167:00 amRNSDisposal
26th Aug 201612:15 pmRNSTrading Update
30th Jun 20162:54 pmRNSHolding(s) in Company - Replacement
30th Jun 20162:17 pmRNSHolding(s) in Company
22nd Feb 20169:45 amRNSInterim Results
15th Oct 20151:02 pmRNSResult of AGM
25th Sep 20157:00 amRNSTrading Update
3rd Sep 20157:00 amRNSPosting of Annual Report and Dividend Update
27th Aug 201511:37 amRNSFinal Results
25th Aug 201512:09 pmRNSTrading Update
12th Mar 201511:40 amRNSDirector/PDMR Shareholding
19th Feb 201512:28 pmRNSDirector/PDMR Shareholdings
13th Feb 20159:57 amRNSDirector/PDMR Shareholdings
11th Feb 20157:00 amRNSInterim Results
2nd Jan 20157:00 amRNSAcquisition of Ancora Solutions
2nd Jan 20157:00 amRNSDisposal
24th Nov 20147:00 amRNSDirectorate Changes
9th Oct 20142:54 pmRNSResult of AGM
9th Sep 201410:47 amRNSPosting of Annual Report and Notice of AGM
1st Sep 20147:00 amRNSFinal Results
29th Aug 201410:49 amRNSDirectorate Changes
16th Jul 20147:00 amRNSTrading Update
10th Jul 201411:20 amRNSHolding(s) in Company
14th Feb 20147:00 amRNSInterim Results
14th Nov 20132:24 pmRNSDirector/PDMR Shareholdings
14th Nov 20138:54 amRNSHolding(s) in Company
5th Nov 20135:57 pmRNSGrant of Options
1st Nov 20134:29 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.